Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

A new therapy for a skin blistering condition has not been developed yet.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

DPCP is more effective than tretinoin gel for treating severe alopecia.